Jane Wasman

Track

Insider profile

Currently holds a position at Rigel Pharmaceuticals Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 30% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Rigel Pharmaceuticals Inc March 22, 2019 -
Jane Wasman's trades of Sellas Life Sciences Group Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-02 2025-05-30
B Purchase
85,009 +38.1%
431.04
US$91,696 		85,009 +38.1% 431.04 US$91,696
2019-12-04 2019-12-02
PlS Planned sale
8,437 +12.8%
479.39
US$1,360,191 		8,437 +12.8% 479.39 US$1,360,191
2018-12-06 2018-12-03
PlS Planned sale
45,336 +38.3%
239.93
US$4,592,320 		45,336 +38.3% 239.93 US$4,592,320
2017-12-05 2017-12-01
PlS Planned sale
4,564 -4.3%
20.52
US$93,662 		4,564 -4.3% 20.52 US$93,662
2016-10-05 2016-10-03
PlS Planned sale
3,750 -3.4%
20.78
US$77,927 		3,750 -3.4% 20.78 US$77,927